Back
Sarepta Therapeutics 10K Form
Sell
49
SRPT
Sarepta Therapeutics
Last Price:
130.47
Seasonality Move:
14.88%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive SRPT News And Ratings
See the #1 stock for the next 7 days that we like better than SRPT
SRPT Financial Statistics
Sales & Book Value
| Annual Sales: | $1.24B |
|---|---|
| Cash Flow: | $-107.96M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $12.79 |
| Price / Book: | 10.21 |
Profitability
| EPS (TTM): | 1.54000 |
|---|---|
| Net Income (TTM): | $121.85M |
| Gross Margin: | $1.09B |
| Return on Equity: | 12.48% |
| Return on Assets: | 3.67% |
Sarepta Therapeutics Earnings Forecast
Key Sarepta Therapeutics Financial Ratios
- The Gross Profit Margin over the past 28 years for SRPT is 87.91%.
- The Selling, General & Administrative Expenses for SRPT have been equal to 38.76% of Gross Profit Margin.
- The Research & Development expenses have been 70.57% of Revenue.
- The Interest Expense is -4.11% of Operating Income.
- The Net Earning history of SRPT is -43.11% of Total Revenues.
- Per Share Earnings over the last 28 years have been positive in 14 years.
Sarepta Therapeutics Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | SRPT |
| CUSIP: | 803607 |
| Website: | sarepta.com |
Debt
| Debt-to-Equity Ratio: | 1.01 |
|---|---|
| Current Ratio: | 3.84 |
| Quick Ratio: | 2.45 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 10.37 |
SRPT Technical Analysis vs Fundamental Analysis
Sell
49
Sarepta Therapeutics (SRPT)
is a Sell
Is Sarepta Therapeutics a Buy or a Sell?
-
Sarepta Therapeutics stock is rated a Sell
The current Sarepta Therapeutics [SRPT] share price is $130.50. The Score for SRPT is 49, which is 2% below its historic median score of 50, and infers higher risk than normal.